No insider purchase over the last 90 days. The latest, by BENARROCH GEORGES, was filed 11 Jan 2010.
Kyto Biopharma Inc is a listed company. Its directors and officers file their transactions with SEC (Form 4). Kyto Biopharma Inc has had no insider filing for more than a year; the last one goes back to 14 April 2021.
The full history, which starts in 2006, counts 2 purchases against 2 sales.
These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
FY ended March 2020 · cache
19 of 19 declarations
Kyto Biopharma Inc is a company focused on developing biopharmaceutical solutions. It is listed on the XNAS market.